1) The FCC has approved a waiver of some of the technical rules applicable to ultra-wideband (UWB) devices to enable marketing and sale of a medical device by Kyma Medical Technologies Limited. Kyma states that the uCor device is an advanced RF diagnostic tool that non-invasively monitors lung and fluid levels and trends to treat patients with congestive heart failure (CHF). The device employs a very low power RF signal that is directed into the patient’s torso via a small transmitter that is temporarily attached to the skin. Signals from the uCor propagate through the chest and lungs and reflect back from the heart. Data collected by the uCor is transferred via standard wireless interface over the internet and on to a data center where it can be analyzed by a healthcare provider. The extremely low power and low duty cycle device operates with stepped frequency modulation in 25 MHz steps across the 530 MHz to 2105 MHz spectrum. NPSTC had supported the waiver grant when the FCC placed Kyma’s request on public notice.
KYMA MEDICAL TECHNOLOGIES LTD/REQUEST FOR WAIVER OF PART 15 OF THE COMMISSION’S RULES APPLICABLE TO ULTRA-WIDEBAND DEVICES. OET grants a request by Kyma Medical Technologies Ltd. (Kyma) to waive certain of our rules for unlicensed ultra-wideband (UWB) devices to permit the certification and marketing of its medical imaging and diagnostic device, the uCor 3.0 (uCor). (Dkt No. 15-119 ). Action by: Chief, Office of Engineering and Technology. Adopted: 09/06/2016 by ORDER. (DA No. 16-1009). OET https://apps.fcc.gov/edocs_public/attachmatch/DA-16-1009A1.pd